Secondary analysis of MISTIE III (89 patients with intracerebral haemorrhage): higher haematoma IL-1 receptor antagonist (OR 5.92; n=38) and IL-6 (OR 3.23; n=45) were independently associated with good 1-year outcome (mRS 0-3). Plasma cytokines did not differ by treatment.
Secondary analysisn = 89
Parry-Jones et al. Hematoma Interleukin-1 Receptor Antagonist Concentrations Predict Long-Term Outcome in Acute Human Intracerebral Hemorrhage